Concepedia

Author

Canming Chen

Fudan University Shanghai Cancer Center

Also Known As

Can-Ming Chen, Can-ming Chen, Canming Chen, Can‐Ming Chen

45

Publications

587

Citations

12

H-Index

19

Concepts

All Affiliations

Fudan University Shanghai Cancer CenterShanghai Medical College of Fudan UniversityFudan UniversityJiangsu Hengrui Medicine (China)Ministry of Water Resources of the People's Republic of China
CC

About

Canming Chen is an author at Fudan University Shanghai Cancer Center specializing in medicine, breast cancer, and oncology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

3

3

102

2

Pathology

2

2

58

3

Health Sciences

1

1

47

4

Immunology

1

1

11

5

Pharmacology

1

1

11

Canming Chen

×

16

Publications

551

Citations

12

H-Index

YearCitations

Tumor Associated Macrophage × Cancer Cell Hybrids May Acquire Cancer Stem Cell Properties in Breast Cancer

Jingxian Ding, Wei Jin, Canming Chen,

PLoS ONE

2012

120

Famitinib with Camrelizumab and Nab-Paclitaxel for Advanced Immunomodulatory Triple-Negative Breast Cancer (FUTURE-C-Plus): An Open-Label, Single-Arm, Phase II Trial

Li Chen, Yi‐Zhou Jiang, Song‐Yang Wu,

Clinical Cancer Research

2022

89

The Role of Mammographic Calcification in the Neoadjuvant Therapy of Breast Cancer Imaging Evaluation

Jun-Jie Li, Canming Chen, Yajia Gu,

PLoS ONE

2014

50

Identification of a Comprehensive Spectrum of Genetic Factors for Hereditary Breast Cancer in a Chinese Population by Next-Generation Sequencing

Xiaochen Yang, Jiong Wu, Jingsong Lu,

PLoS ONE

2015

47

Estrogen receptor-related genes as an important panel of predictors for breast cancer response to neoadjuvant chemotherapy

Yizuo Chen, Canming Chen, Benlong Yang,

Cancer Letters

2011

44

Concurrent neoadjuvant chemotherapy and estrogen deprivation in patients with estrogen receptor–positive, human epidermal growth factor receptor 2–negative breast cancer (CBCSG‐036): A randomized, controlled, multicenter trial

Ke‐Da Yu, Si‐Yu Wu, Guangyu Liu,

Cancer

2019

42

Efficacy and Safety of Docetaxel Combined With Oxaliplatin as a Neoadjuvant Chemotherapy Regimen for Chinese Triple-Negative Local Advanced Breast Cancer Patients

Fei Fei, Canming Chen, Jingyan Xue,

American Journal of Clinical Oncology

2012

26

A prognostic model to predict outcome of patients failing to achieve pathological complete response after anthracycline‐containing neoadjuvant chemotherapy for breast cancer

Sheng Chen, Canming Chen, Ke‐Da Yu,

Journal of Surgical Oncology

2011

22

Prognostic and predictive value of Phospho-p44/42 and pAKT in HER2-positive locally advanced breast cancer patients treated with anthracycline-based neoadjuvant chemotherapy

Liang Huang, Tianwen Chen, Canming Chen,

World Journal of Surgical Oncology

2013

21

The clinicopathological and MRI features of patients with BRCA1/2 mutations in familial breast cancer

Chao You, Qin Xiao, Xinyi Zhu,

Gland Surgery

2021

17

Page 1